Scholars Central

Conference abstractPublished 20 Jun 2016

New transition metal complexes of enantiomeric benzimidazol derivatives in presence of dinitrogen or phosphorous aromatic donors: Synthesis, characterization and DNA interaction

Authors: Sahar I Mostafa

Mansoura University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the pharmacological field, it is very important to prove the efficacy of chiral or enantiopure drugs; i.e., single enantiopure drugs have been shown to be better due to its safe and potent effect in comparison to the racemate drugs. Chiral drugs are assumed to be therapeutically active as most of the bio-targets of drugs are chiral in nature. Thus, considerable attention has been paid to chiral molecules design and construct that are versatile in occupying the active site, possess a metal-binding domain and have a bioactive organic functionality (pharmacophore), which pre-orients the molecule as a drug entity and reduces the toxicity parameters. The introduction of chirality enhances the pharmacological behavior of a metal complex by adopting a specific conformation and a target selective binding affinity for DNA (as DNA itself exists in nature only in one chiral form). The design of metal-based pharmaceuticals depends on the donor framework, the metal ion and its oxidation state. The donors can significantly alter the biological properties by modifying reactivity or substitution inertness. Tailored, multifunctional donors introduced into the metal-based medicinal agents facilitate metal ion redistribution, limit the adverse effects of metal ion overload and inhibit selected metalloenzymes. Therefore, chiral metal complexes have a promising future as robust chemotherapeutic agents in medicinal inorganic chemistry. This study is aimed to preparation of new chiral nucleases derived from Ã?Â?- and âÂ?§-benzimidazol derivative (H2bie) complexes of Zn(II), Pd(II), Pt(II) and Ag(I), in absence and presence of 2,2âÂ?Â?-bipyridyl, 1,10-phenanthroline and triphenylphosphine frameworks. Their structures are discussed on the bases of spectroscopic (IR, Raman, UV-Vis, NMR (1H, 13C and 31P) and mass), elemental analysis, molar conductivity and thermal degradation measurements. The in vitro anticancer activity of free Ã?Â?-H2bie and âÂ?§-H2bie and their complexes were evaluated against two of the most famous, human breast cancer (MDA-MB231) and human ovarian cancer (OVCAR-8) cell lines. The enantio-selective complex DNA binding by circular dichroism (CD) furnishes direct information on how the DNA helix and enantiomeric complexes interact and thus reveal the influence of each enantiomer of a given complex on the DNA-binding strength. Comparisons of the CD spectra of pair of enantiomers, Ã?Â?-H2bie and âÂ?§-H2bie complexes in 5 mM phosphate buffer 50 mM NaCl (pH 7.2) have been measured and the results indicate intercalative CT-DNA binding capabilities.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Pharmaceutical Care & Health Systems.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical Care & Health Systems
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sahar I Mostafa”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels